ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
Dow Jones
39.112,16
-0,76%
Euro vs US Dollar
1,07116
0,02%
Bitcoin
61.752,83
-0,08%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Rain Oncology Inc (RAIN)

  7. Rain Oncology Inc (RAIN) News

RAIN

Rain Oncology (RAIN)

Rain Oncology Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:RAIN
DatumZeitQuelleÜberschriftSymbolFirma
05/02/202412h41Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:RAINRain Oncology Inc
31/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RAINRain Oncology Inc
26/01/202422h58Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RAINRain Oncology Inc
26/01/202422h56Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RAINRain Oncology Inc
26/01/202422h55Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RAINRain Oncology Inc
26/01/202422h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
26/01/202422h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
26/01/202422h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
26/01/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
26/01/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
26/01/202422h32Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:RAINRain Oncology Inc
26/01/202415h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
26/01/202415h19Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RAINRain Oncology Inc
26/01/202415h13Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:RAINRain Oncology Inc
22/01/202422h15Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RAINRain Oncology Inc
19/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
16/01/202423h22Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RAINRain Oncology Inc
16/01/202423h18Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:RAINRain Oncology Inc
03/01/202420h57PR Newswire (US)Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law FirmNASDAQ:RAINRain Oncology Inc
29/12/202302h48Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:RAINRain Oncology Inc
27/12/202315h27Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:RAINRain Oncology Inc
27/12/202315h20Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:RAINRain Oncology Inc
14/12/202312h06Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:RAINRain Oncology Inc
14/12/202312h06Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:RAINRain Oncology Inc
14/12/202312h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
09/11/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RAINRain Oncology Inc
09/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
12/09/202311h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
06/09/202311h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
29/08/202311h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:RAIN

Kürzlich von Ihnen besucht

TG
A19E10
Engie
NYSE
WBS-F
Webster Financial
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten